Technical Analysis for MURA - Mural Oncology plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Fell Below 20 DMA | Bearish | -1.70% | |
| Down 3 Days in a Row | Weakness | -1.70% | |
| Gapped Down | Weakness | -1.70% | |
| NR7 | Range Contraction | -2.81% | |
| MACD Bearish Signal Line Cross | Bearish | -3.62% | |
| MACD Bullish Signal Line Cross | Bullish | -4.68% | |
| 180 Bullish Setup | Bullish Swing Setup | -4.68% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 20 hours ago |
| 10 DMA Resistance | about 20 hours ago |
| Down 2 % | about 20 hours ago |
| Down 1% | about 20 hours ago |
| Up 1% | about 20 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Our expertise in cytokine biology and immune cell modulation and our unmatched protein engineering will enable us to develop medicines that deliver meaningful and clinical benefits to people living with cancer. Our mission is to broaden the potential and reach of cytokine-based immunotherapies to improve the lives of patients. Mural Oncology has its registered office in Dublin, Ireland, and its primary facilities in Waltham, Mass.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunotherapy Treatment Of Cancer Oncology Immunotherapies Virotherapy Cytokine Protein Engineering
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunotherapy Treatment Of Cancer Oncology Immunotherapies Virotherapy Cytokine Protein Engineering
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.0 |
| 52 Week Low | 2.88 |
| Average Volume | 90,383 |
| 200-Day Moving Average | 3.79 |
| 50-Day Moving Average | 3.35 |
| 20-Day Moving Average | 3.53 |
| 10-Day Moving Average | 3.55 |
| Average True Range | 0.17 |
| RSI (14) | 49.75 |
| ADX | 23.05 |
| +DI | 22.80 |
| -DI | 20.73 |
| Chandelier Exit (Long, 3 ATRs) | 3.41 |
| Chandelier Exit (Short, 3 ATRs) | 3.58 |
| Upper Bollinger Bands | 3.73 |
| Lower Bollinger Band | 3.32 |
| Percent B (%b) | 0.33 |
| BandWidth | 11.61 |
| MACD Line | 0.06 |
| MACD Signal Line | 0.07 |
| MACD Histogram | -0.0168 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.66 | ||||
| Resistance 3 (R3) | 3.67 | 3.62 | 3.62 | ||
| Resistance 2 (R2) | 3.62 | 3.57 | 3.61 | 3.61 | |
| Resistance 1 (R1) | 3.54 | 3.54 | 3.52 | 3.53 | 3.60 |
| Pivot Point | 3.49 | 3.49 | 3.48 | 3.48 | 3.49 |
| Support 1 (S1) | 3.41 | 3.44 | 3.39 | 3.40 | 3.32 |
| Support 2 (S2) | 3.36 | 3.41 | 3.35 | 3.31 | |
| Support 3 (S3) | 3.28 | 3.36 | 3.30 | ||
| Support 4 (S4) | 3.27 |
